logo
Endocrine Society Statement Outlines Knowledge Gaps in T1D

Endocrine Society Statement Outlines Knowledge Gaps in T1D

Medscape11-07-2025
A new Endocrine Society scientific statement outlines 'challenges and opportunities' in understanding the pathogenesis of type 1 diabetes (T1D), with some clinical takeaways regarding the heterogeneity of the condition and the need for increased screening for preclinical disease.
The statement was published on July 9, 2025 in The Journal of Clinical Endocrinology & Metabolism and will be presented July 14, 2025 at ENDO 2025: The Endocrine Society Annual Meeting.
It summarizes what is known and what is still to be learned about the autoimmune process leading to pancreatic beta cell destruction, the genetics and immunology involved, and the heterogeneity of the patient population, including the large but often unrecognized group who develop the condition in adulthood.
The statement also reviews recent advances in the early identification of preclinical T1D and the emergence of stategies to delay onset including teplizumab (Tzield), which is already on the market.
'It's such an incredibly exciting time in type 1 diabetes now, on so many different levels, that the Endocrine Society felt that it was a good time to talk about the pathogenesis,' writing committee member Alvin C. Powers, MD, professor of medicine and director of the Diabetes Center at Vanderbilt University, Nashville, Tennessee, told Medscape Medical News .
The heterogeneity of T1D is important to recognize clinically, particularly the high incidence of new-onset T1D in adults despite its former characterization as a 'juvenile' disease. 'We now think that maybe a third of people who have type 1 develop it over the age of 30, maybe even 40%,' Powers noted.
But, often in adulthood the beta cell destruction is slower and individuals may not require insulin treatment right away, leading to a potential misdiagnosis of type 2 diabetes. Other sources of heterogeneity outlined in the document include the severity of hyperglycemia at onset, the intensity of islet-directed autoimmunity, contributors such as obesity and insulin resistance, and rate/degree of beta cell loss.
Asked to comment, endocrinologist M. Sue Kirkman, MD, professor of medicine at the University of North Carolina at Chapel Hill, told Medscape Medical News, 'The statement provides clear descriptions of what we do and especially still don't know about the pathogenesis of type 1 diabetes. The knowledge gaps and suggested future efforts may be of the most interest to more basic researchers, but as an adult endocrinologist, I appreciated the emphasis on the need to understand adult-onset type 1 diabetes more.'
The document also reviews the three stages of T1D: In stage 1, the individual has two or more autoantibodies directed against glutamic acid decarboxylase, insulin, insulinoma antigen-2 and/or zinc transporter 8, but glycemia is still normal. In stage 2, there are multiple autoantibodies and dysglycemia, but not yet to the point of insulin requirement. Stage 3 is clinical T1D.
Powers noted, 'there is great interest in trying to understand the pathogenesis and screen individuals who are at high risk for developing type 1 diabetes, because there now is one disease-modifying therapy out there. In order to get that, people are going to have to be identified as having one of these autoantibodies.'
When Is Preventive Screening Warranted?
General population screening isn't yet universal, but 'certainly people who have a family member with type 1 diabetes should be screened for this, even though we know that 75% of people who have type 1 diabetes don't have anybody else in their family with it. But if you have someone with type 1 diabetes in your family, you are at higher risk and should be screened and if positive, should be referred to a center of excellence that is involved in administering [teplizumab],' Powers recommended, adding that it does have side effects and is fairly expensive.
However, he also noted, the value of such screening in adults and in relatives of those with adult-onset T1D is unclear. 'These antibodies are great at predicting whether a 12-year-old sibling of someone who has type 1 diabetes is going to get diabetes but what we don't know is about a 52-year-old who develops what we think is type 1 diabetes, when did they start having autoantibodies, in their teenage years, or did those antibodies form when they were in their 40's? We don't have a clue about that.'
Indeed, Kirkman pointed out, 'the issue of screening for T1D risk in adults is murky, since these people have avoided childhood-onset disease so the more well-known risk factors may not be as predictive. It's also important to stress that a lot of what we know is based on children and younger people of White European descent, whereas there are many people of other races/ethnicities that develop type 1 diabetes.'
Powers is involved in a study called RADIANT exploring the overall heterogeneity of diabetes and currently enrolling people who don't fit the typical pictures of type 1 or type 2 diabetes.
Powers and Kirkman had no disclosures.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Michigan man aims to bring adult changing tables to public spaces
Michigan man aims to bring adult changing tables to public spaces

CBS News

time4 minutes ago

  • CBS News

Michigan man aims to bring adult changing tables to public spaces

Changing tables are often associated with infants or young children, but there is another population in need of the accessible devices: teenagers and adults with disabilities. In most cases, caregivers are forced to change them on the floors of cars or bathrooms. Sometimes, there is no choice but to change them in public, in full view of others with no privacy. Joshua Taylor has made it his life's mission to make adult changing tables mainstream in Michigan. Due to a genetic condition that affects his connective tissues, Taylor has experienced a decline in mobility and began experiencing incontinence. "I realized that this wasn't a convenience," said Taylor. "This was a need. And not just for me but for tens of thousands of people just in our communities and millions of people across the country." He, too, has been faced with the challenge of figuring out a place to change when a changing table wasn't available. "I have had to use the back seat of my sedan to change," he said. "I have had to lay on a dirty bathroom floor and put as much padding or blankets down as possible, or even just not go out. "Even if I am able to go out, it might mean sitting in a soiled garment for hours because of the lack of accessible restrooms available." He said people typically stay home rather than risk going outside and feeling stuck when a restroom isn't an option. "Think about how much more people can get out of life having this available," he said. There are several models of adult changing tables available. One at Dodge Park in Commerce Township has a lift that can bear 1,000 lbs. Taylor is working with various local and state officials to install the changing tables across Michigan. He's also the Michigan chair of the national organization Changing Spaces USA. "Through the advocacy of myself, through the advocacy of countless others, we're hoping to get as many places as possible to have adult changing tables available," he said. A list of Changing Spaces USA's interactive map of adult changing table locations can be found here.

AMA and other medical associations are kicked out of CDC vaccine workgroups
AMA and other medical associations are kicked out of CDC vaccine workgroups

Yahoo

time32 minutes ago

  • Yahoo

AMA and other medical associations are kicked out of CDC vaccine workgroups

NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations. The government told the organizations on Thursday via email that their experts are being disinvited from the workgroups that have been the backbone of the Advisory Committee on Immunization Practices. The organizations include the American Medical Association, the American Academy of Pediatrics and the Infectious Diseases Society of America. 'I'm concerned and distressed,' said Dr. William Schaffner, a Vanderbilt University vaccine expert who for decades has been involved with ACIP and its workgroups. He said the move will likely propel a confusing fragmentation of vaccine guidance, as patients may hear the government say one thing and hear their doctors say another. One email said the organizations are 'special interest groups and therefore are expected to have a 'bias' based on their constituency and/or population that they represent.' A federal health official on Friday confirmed the action, which was first reported by Bloomberg. The decision was the latest development in what has become a saga involving the ACIP. The committee, created in 1964, makes recommendations to the Centers for Disease Control and Prevention on how vaccines that have been approved by the Food and Drug Administration should be used. CDC directors have traditionally almost always approved those recommendations, which are widely heeded by doctors and greenlight insurance coverage for shots. U.S. Health Secretary Robert F. Kennedy Jr. was a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official, and in June abruptly fired the entire ACIP after accusing them of being too closely aligned with manufacturers. He handpicked replacements that include several vaccine skeptics. The workgroups typically include committee members and experts from medical and scientific organizations. At workgroup meetings, members evaluate data from vaccine manufacturers and the CDC, and formulate vaccination recommendation proposals to be presented to the full committee. The structure was created for several reasons, Schaffner said. The professional groups provide input about what might and might not be possible for doctors to implement. And it helped build respect and trust in ACIP recommendations, having the buy-in of respected medical organizations, he said. Workgroup members are vetted for conflicts of interest, to make sure than no one who had, say, made money from working on a hepatitis vaccine was placed on the hepatitis committee, Schaffner noted. Also disinvited from the groups were the American Academy of Family Physicians, the American College of Physicians, the American Geriatrics Society, the American Osteopathic Association, the National Medical Association and the National Foundation for Infectious Diseases. In a joint statement Friday, the AMA and several of the other organizations said: 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' They urged the administration to reconsider the move "so we can continue to feel confident in its vaccine recommendations for our patients.' Some of the professional organizations have criticized Kennedy's changes to the ACIP, and three of the disinvited groups last month joined a lawsuit against the government over Kennedy's decision to stop recommending COVID-19 vaccines for most children and pregnant women. In a social media post Friday, one of the Kennedy-appointed ACIP members — Retsef Levi — wrote that the working groups 'will engage experts from even broader set of disciplines!' Levi, a business management professor, also wrote that working group membership 'will be based on merit & expertise — not membership in organizations proven to have (conflicts of interest) and radical & narrow view of public health!' HHS officials have not said which people are going to be added to the ACIP workgroups. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Mike Stobbe, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The Films and Shows You Should Be Streaming in August 2025
The Films and Shows You Should Be Streaming in August 2025

Gizmodo

time33 minutes ago

  • Gizmodo

The Films and Shows You Should Be Streaming in August 2025

A new era of streaming selections is here. For the past several years, our monthly column, the Nerd's Watch, has been the place to find out all the best genre titles coming to the biggest streaming services. It wasn't a complete list. We just posted the titles we think you'd care about, but it was still long, and frankly, it was hard to pick out the best of the best. Months before the new remake with Jack Black and Paul Rudd, revisit the iconic camp classic with Ice Cube and Jennifer Lopez. It wasn't meant to be a camp classic, but it is now. Groundhog Day is one of those movies that just gets better and better the more you watch it. It's so expertly put together, so funny, so heartfelt. Just a true modern classic. We're onto our third Jurassic Park trilogy, but the original—Jurassic Park, The Lost World, and the underrated Jurassic Park III—are all reemerging on Netflix this month. Just in time for its 40th anniversary, the John Hughes comedy about two nerds who create a woman in a computer is popping up on two streamers. It's incredibly dated but also, thanks to John Hughes, still pretty delightful. Call them the Paul Walker years. The first seven Fast and Furious movies are all coming to Netflix (as well as Hobbs and Shaw), and you can make an argument that it was the passing of Walker, during Furious 7, that derailed the whole thing. Hopefully things get back up to speed in the future, but at least we'll always have these movies (and Hobbs and Shaw, unfortunately). The star-studded adaptation of the iconic Douglas Adams novel is nowhere near as good as the source material, but is anything? That the movie shared even a sliver of the genius and fun of the novel makes this one worth watching. Remember when Aaron Taylor-Johnson and Chloë Grace Moretz co-starred in one of the best superhero movies ever, alongside Nicolas Cage, and directed by Matthew Vaughn? Well, if not, now is the time to watch it again. J.J. Abrams writes and directs this Amblin-inspired tale of a group of kids who film a train crash, only to realize it's at the center of mysterious happenings around town. I've been meaning to revisit this one. One of the weirdest movies you'll see this year is this Stephen King adaptation, produced by James Wan and directed by Osgood Perkins. It's about a family tied in with a toy monkey that kills people seemingly at random. It's super violent and super funny. I'm writing this one more for myself than anyone else. Stranger Things star Finn Wolfhard co-directed this camp-based slasher movie that looks like a lot of fun. I missed it in theaters but definitely will check it out on streaming. Please refer to the above video. From Anna Boden and Ryan Fleck, the directors of Captain Marvel, comes this 'freaky' retro anthology starring Pedro Pascal, Ben Mendelsohn, Dominique Thorne, and other actors who aren't in Marvel movies. You may have missed it, but earlier this year, A24 released this very unique and gorgeous film about a seemingly regular rural town that's thrown into peril because of a group of nearby creatures. Creatures that one of the young women in the town becomes friends with. Willem Dafoe is among the stars. It'll be about a year until we next see James Gunn's DC Universe on the big screen, but before then, it'll be very active on HBO Max. First up, season two of the irreverent Peacemaker starring John Cena. It ties directly into the events of Superman and pushes the whole narrative forward. Have you ever wanted to know more about Wakanda in the Marvel Cinematic Universe? Well, this new animated series is just the ticket. I feel like I'm in Edge of Tomorrow with how I always repeat myself, but here it goes again. Every time Edge of Tomorrow, the Tom Cruise-Emily Blunt time loop sci-fi action film, appears on a streamer, I will let you know. If you stream it, we will watch. It's not quite Edge of Tomorrow, but if you want another super solid Tom Cruise sci-fi film, this one from Joseph Kosinski, the director of Tron: Legacy, Top Gun: Maverick, and F1, well, here you go. After a season with equal parts character and carnage, the video game adaptation starring Anthony Mackie is back. And, this season, it's all about the car battle royale that made the series so popular. One of the more underrated films of 2024 was this incredibly visceral action film starring and directed by Dev Patel. Highly recommended. Spike Jonze directs, Charlie Kaufman writes, and Nicolas Cage stars alongside Meryl Streep, Chris Cooper, and others. Not many movies could live up to that incredible roster, but this one does. There have been seven Paranormal Activity movies, and the first six (1, 2, 3, 4, Ghost Dimension, and Marked Ones) are all coming to Paramount+. Some are better than others, but it's a really strong, scary, found-footage franchise. Jim Carrey stars as a man who lives a pretty great life until he figures out he's the star of the world's largest reality TV series. A modern classic that gets better and better with age. One of those 1990s slashers that came out in the wake of Scream and has its fans, as well as its haters. We're in the first camp, what about you? Weeks after becoming probably the first indie horror movie to get its own corn maze at San Diego Comic-Con, the horror movie with the perfect, direct title is coming to streaming. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what's next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store